Sinovac Biotech Ltd.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Sinovac Biotech Ltd.'s past years’ income statements indicate that its last revenue has decreased compared to the previous period by 70% to $448,269,000. Profit margin reached -22%. Total operating expenses were $813,477,000.

Profit Margin

Sinovac Biotech Ltd. (NASDAQ:SVA): Profit margin
2014 62.93M -1.51M -2.41%
2015 67.41M -1.41M -2.1%
2016 72.43M -596K -0.82%
2017 174.34M 25.80M 14.8%
2018 229.65M 21.78M 9.48%
2019 246.05M 44.92M 18.26%
2020 510.62M 110.36M 21.61%
2021 19.37B 8.46B 43.7%
2022 1.49B 113.86M 7.63%
2023 448.26M -99.91M -22.29%

SVA Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
448.26M1.49B19.37B510.62M246.05M229.65M174.34M72.43M67.41M62.93M
Cost of revenue
181.51M684.45M1.07B67.18M32.46M24.72M20.24M22.39M18.40M15.47M
Gross profit
266.75M808.30M18.30B443.44M213.58M204.92M154.10M50.03M49.00M47.45M
Operating exp.
Research and development
344.51M442.10M155.04M48.76M24.25M21.91M20.48M12.64M9.49M10.93M
Selling and marketing
0000000000
Total operating expenses
813.47M1.26B748.44M227.63M144.72M159.53M108.64M49.05M45.28M45.49M
Operating income
-546.72M-466.06M17.55B215.64M68.56M45.31M45.41M504K3.69M1.88M
Other income (expenses), net
393.69M296.53M-90.92M973K618K246K-373K-378K-939K463K
Income before tax
-153.03M25.23M17.56B216.61M70.82M46.58M45.04M-394K2.75M2.34M
Income tax expense
105.32M-62.89M3.10B31.43M5.60M10.47M8.33M2.66M2.98M2.06M
Net income
-99.91M113.86M8.46B110.36M44.92M21.78M25.80M-596K-1.41M-1.51M
Earnings per share
Basic EPS
-1.061.0885.21.060.420.340.45-0.01-0.02-0.02
Diluted EPS
-1.06174.270.970.410.340.45-0.01-0.02-0.02
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source